| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/00498259009046849 |
| P698 | PubMed publication ID | 2336840 |
| P2093 | author name string | Mechoulam R | |
| Harvey DJ | |||
| P433 | issue | 3 | |
| P304 | page(s) | 303-320 | |
| P577 | publication date | 1990-03-01 | |
| P1433 | published in | Xenobiotica | Q1360678 |
| P1476 | title | Metabolites of cannabidiol identified in human urine | |
| P478 | volume | 20 |
| Q41016981 | A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans |
| Q30670447 | A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis |
| Q45292449 | Assay of plasma cannabidiol by capillary gas chromatography/ion trap mass spectroscopy following high-dose repeated daily oral administration in humans |
| Q34657897 | Cannabidiol in humans-the quest for therapeutic targets |
| Q34948216 | Cannabidiol: a promising drug for neurodegenerative disorders? |
| Q35035808 | Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects |
| Q44025994 | Cannabielsoin as a new metabolite of cannabidiol in mammals |
| Q43593896 | Cannabinoid-induced alterations in brain disposition of drugs of abuse |
| Q34462104 | Catecholamines and methods for their identification and quantitation in biological tissues and fluids. |
| Q67881074 | Comparative metabolism of cannabidiol in dog, rat and man |
| Q91276380 | Decarbonylation: A metabolic pathway of cannabidiol in humans |
| Q50960906 | Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography-Tandem Mass Spectrometry |
| Q42317501 | Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction |
| Q41560648 | Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy |
| Q24652736 | Human cannabinoid pharmacokinetics |
| Q36987924 | Impact of enzymatic and alkaline hydrolysis on CBD concentration in urine |
| Q90095461 | Is cannabidiol a drug acting on unconventional targets to control drug-resistant epilepsy? |
| Q67896622 | Metabolism of cannabidiol by the rat |
| Q34185013 | Pharmacokinetics and pharmacodynamics of cannabinoids |
| Q57176921 | Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)-a pilot study |
| Q67914618 | Sex difference in the oxidative metabolism of Δ9-tetrahydrocannabinol in the rat |
| Q54243217 | Simultaneous quantification of major cannabinoids and metabolites in human urine and plasma by HPLC-MS/MS and enzyme-alkaline hydrolysis. |
| Q98507441 | The Essential Medicinal Chemistry of Cannabidiol (CBD) |
Search more.